Oral diseases · 2026
Low Margin-To-Depth of Invasion Ratio Plus pN1 Predict Poor Prognosis in Oral Cancer Without Adverse Features.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Fang Ko-Chun, Tsai Yao-Te, Chuang Hui-Ching, Lin Yu-Tsai, Fang Fu-Min, Yang Chao-Hui, Lu Hui, Tsai Wen-Ling, Tsai Ming-Hsien
Аннотация
OBJECTIVE: To evaluate the prognostic value of the margin-to-depth of invasion ratio (MDR) combined with nodal classification in stages I-III oral squamous cell carcinoma (OSCC) without conventional adverse pathological features (CAPFs) treated with curative resection alone.
METHODS: This retrospective study included 820 patients with pT1-3N0-1 OSCC without CAPFs treated with curative resection without adjuvant therapy between January 2005 and April 2017 at a tertiary referral center. The MDR cutoff was identified using Youden's index with bootstrap validation. Cancer-specific survival (CSS) and relapse-free survival (RFS) were analyzed using Cox models.
RESULTS: An MDR cutoff of 0.92 stratified outcomes. MDR ≥ 0.92 was associated with better 5-year CSS (96.8% vs. 90.0%; p < 0.001) and RFS (88.6% vs. 81.5%). Low MDR and pN1 were independent adverse predictors. The combined cohort identified a small but highly aggressive subgroup: patients with low MDR plus pN1 (n = 16) had the worst outcomes (5-year CSS 56.3%, 95% CI: 36.5%-86.7%; 5-year RFS 37.5%, 95% CI: 19.9%-70.6%) compared with the other subgroups.
CONCLUSION: Low MDR plus pN1 identified a high-risk subgroup in OSCC without CAPFs; accordingly, patients with both features might require closer surveillance and further evaluation of adjuvant treatment strategies in clinical situations.
METHODS: This retrospective study included 820 patients with pT1-3N0-1 OSCC without CAPFs treated with curative resection without adjuvant therapy between January 2005 and April 2017 at a tertiary referral center. The MDR cutoff was identified using Youden's index with bootstrap validation. Cancer-specific survival (CSS) and relapse-free survival (RFS) were analyzed using Cox models.
RESULTS: An MDR cutoff of 0.92 stratified outcomes. MDR ≥ 0.92 was associated with better 5-year CSS (96.8% vs. 90.0%; p < 0.001) and RFS (88.6% vs. 81.5%). Low MDR and pN1 were independent adverse predictors. The combined cohort identified a small but highly aggressive subgroup: patients with low MDR plus pN1 (n = 16) had the worst outcomes (5-year CSS 56.3%, 95% CI: 36.5%-86.7%; 5-year RFS 37.5%, 95% CI: 19.9%-70.6%) compared with the other subgroups.
CONCLUSION: Low MDR plus pN1 identified a high-risk subgroup in OSCC without CAPFs; accordingly, patients with both features might require closer surveillance and further evaluation of adjuvant treatment strategies in clinical situations.